Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.660
+0.006 (0.92%)
Dec 20, 2024, 4:00 PM EST - Market closed
Passage Bio Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$8.00
Upside
+1,112.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Initiates $4 | Buy | Initiates | $4 | +506.06% | Nov 29, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +960.61% | Nov 14, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +1,869.70% | Nov 14, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +1,869.70% | May 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +2,021.21% | Mar 5, 2024 |
| Raymond James | Raymond James | Buy Maintains $9 → $5 | Buy | Maintains | $9 → $5 | +657.58% | Nov 14, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +1,263.64% | Aug 8, 2023 |
| Raymond James | Raymond James | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +1,263.64% | May 12, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $18 → $11 | Strong Buy | Maintains | $18 → $11 | +1,566.67% | Dec 15, 2022 |
| Guggenheim | Guggenheim | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +1,566.67% | Nov 11, 2022 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $5 | Strong Buy | Maintains | $7 → $5 | +657.58% | Nov 11, 2022 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +1,112.12% | Nov 8, 2022 |
| Citigroup | Citigroup | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +1,415.15% | May 17, 2022 |
| Raymond James | Raymond James | Buy Maintains $24 → $10 | Buy | Maintains | $24 → $10 | +1,415.15% | May 17, 2022 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 8, 2022 |
| Raymond James | Raymond James | Buy Maintains $29 → $24 | Buy | Maintains | $29 → $24 | +3,536.36% | Mar 4, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.